Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2652-2664
Author(s):
Robert J. Kreitman
Ribonucleases and ImmunoRNases as Anticancer Drugs
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2665-2675
Author(s):
S. M. Rybak, M. A.E. Arndt, T. Schirrmann, S. Dubel and J. Krauss
Fcγ Receptor 1 (CD64), a Target Beyond Cancer
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2712-2718
Author(s):
T. Thepen, M. Huhn, G. Melmer, M. K. Tur and S. Barth
The Prognosis and Treatment of Adult Acute Leukemia with 11q23/MLL According to the Fusion Partner
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
227-231
Author(s):
Hayato Tamai, Hiroki Yamaguchi, Koiti Inokuchi and Kazuo Dan
Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
595-607
Author(s):
P. Heffeter, A. Popovic-Bijelic, P. Saiko, R. Dornetshuber, U. Jungwirth, N. Voevodskaya, D. Biglino, M. A. Jakupec, L. Elbling, M. Micksche, T. Szekeres, B. K. Keppler, A. Graslund and W. Berger
Targeting the Mevalonate Pathway for Improved Anticancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
626-638
Author(s):
G. Fritz
The Role of Fibroblast Growth Factors in Tumor Growth
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
639-651
Author(s):
M. Korc and R. E. Friesel
Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
690-704
Author(s):
M. Caraglia, M. Marra, P. Tagliaferri, S. W.J. Lamberts, S. Zappavigna, G. Misso, F. Cavagnini, G. Facchini, A. Abbruzzese, L. J. Hofland and G. Vitale
Anti Tumor Necrosis Factor Alpha (TNFα) Therapy in Ankylosing Spondylitis - Asian Perspective
Journal:
Current Rheumatology Reviews
Volume:
5
Page:
158-164
Author(s):
Tsz Yan Lee and Feng Huang
p53-Induced Apoptosis and Inhibitors of p53
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
2627-2640
Author(s):
Surendra Kumar Nayak, Paramjit Singh Panesar and Harish Kumar